Becton Dickinson (BDX) Total Current Liabilities (2009 - 2026)
Becton Dickinson's (BDX) quarterly Total Current Liabilities came in at $8.5 billion in Q1 2026, up 10.61% year-on-year from $7.7 billion in Q1 2025, and down 2.9% on a QoQ basis from $8.8 billion in Q4 2025.
Becton Dickinson (BDX) Total Current Liabilities (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has 18 years of Total Current Liabilities data on file, last reported at $8.5 billion in Q1 2026.
- On a quarterly basis, Total Current Liabilities rose 10.61% year-over-year to $8.5 billion in Q1 2026; TTM through Mar 2026 was $8.5 billion, a 10.61% increase from a year earlier, with the FY2025 full-year figure at $8.3 billion, down 7.18% from the prior year.
- Total Current Liabilities for Q1 2026 stood at $8.5 billion, down from $8.8 billion in the prior quarter.
- Over the last five years, Total Current Liabilities for BDX reached as high as $9.0 billion in Q3 2024 and fell as low as $6.6 billion in Q2 2024.
- Historically, Total Current Liabilities has averaged $7.6 billion across 5 years, with a median of $7.6 billion in 2022.
- Across the five-year window, Total Current Liabilities fell 14.98% in 2023 and jumped 34.86% in 2024, its largest moves.
- Year by year, Total Current Liabilities stood at $7.6 billion in 2022, then fell by 1.11% to $7.5 billion in 2023, then gained by 1.64% to $7.7 billion in 2024, then gained by 14.31% to $8.8 billion in 2025, then fell by 2.9% to $8.5 billion in 2026.
- Per Business Quant data, the three most recent Total Current Liabilities figures were $8.5 billion in Q1 2026, $8.8 billion in Q4 2025, and $8.3 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 3.00 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 1.92 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 8.51 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 2.54 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 1.35 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 640.50 Mn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 1.80 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 3.35 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 1.91 Bn |
| 10 | Baxter International | 11.17 Bn | 9.12 Bn | 891.00 Mn | 3.69 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 8.51 Bn |
| Dec 31, 2025 | 8.76 Bn |
| Sep 30, 2025 | 8.31 Bn |
| Jun 30, 2025 | 8.16 Bn |
| Mar 31, 2025 | 7.69 Bn |
| Dec 31, 2024 | 7.66 Bn |
| Sep 30, 2024 | 8.96 Bn |
| Jun 30, 2024 | 6.61 Bn |
| Mar 31, 2024 | 7.33 Bn |
| Dec 31, 2023 | 7.54 Bn |
| Sep 30, 2023 | 6.64 Bn |
| Jun 30, 2023 | 6.88 Bn |
| Mar 31, 2023 | 7.30 Bn |
| Dec 31, 2022 | 7.63 Bn |
| Sep 30, 2022 | 7.81 Bn |
| Jun 30, 2022 | 7.08 Bn |
| Mar 31, 2022 | 6.66 Bn |
| Dec 31, 2021 | 6.74 Bn |
| Sep 30, 2021 | 6.63 Bn |
| Jun 30, 2021 | 7.75 Bn |